To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended?

GHH van de Loo-Neus, N Rommelse… - European …, 2011 - Elsevier
ADHD is a common neuropsychiatric disorder with a strong persistence over time.
Medication is frequently used in the clinical management of ADHD. After response …

Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge

YS Huang, MH Tsai - Cns Drugs, 2011 - Springer
Attention-deficit hyperactivity disorder (ADHD), a common neuro-behavioural disorder
characterized by inattention, hyperactivity and impulsivity, is a chronic disorder and often …

Using the ASEBA to screen for callous unemotional traits in early childhood: Factor structure, temporal stability, and utility

MT Willoughby, DA Waschbusch, GA Moore… - … of psychopathology and …, 2011 - Springer
This study evaluated a five-item screening measure of Callous Unemotional (CU) traits
using items drawn from the Preschool Form of the Achenbach System of Empirically Based …

Parent and teacher ratings of attention during a year-long methylphenidate trial in children treated for cancer

KL Netson, HM Conklin, JM Ashford… - Journal of Pediatric …, 2011 - academic.oup.com
Objective Longitudinally examine attention performance in childhood cancer survivors
prescribed methylphenidate (MPH) to ameliorate cognitive late effects, comparing measures …

Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD

SH Lee, SW Kim, MG Lee, KH Yook, LL Greenhill… - Psychiatry …, 2011 - Elsevier
This study investigated the relationship between the five common polymorphisms
(rs2242446, rs5568, rs5569, rs998424, and rs1616905) in the norepinephrine transporter …

Methylphenidate-induced visual hallucinations

MC Porfirio, G Giana, S Giovinazzo… - …, 2011 - thieme-connect.com
An 11-year-old boy with attention deficit/hyperactivity disorder (ADHD) presented with visual
hallucinations several years after starting methylphenidate (MPH). The hallucinations …

Prospective, naturalistic study of open-label OROS methylphenidate treatment in Chinese school-aged children with attention-deficit/hyperactivity disorder

Y Zheng, Y Wang, Q Jiong, L Wang, L Zou… - Chinese Medical …, 2011 - journals.lww.com
Background Attention deficit hyperactivity disorder (ADHD) is one of the most common
mental disorders during childhood, characterized by the core symptoms of hyperactivity …

New drug treatments for ADHD

K McBurnett, N Weiss - Psychiatric Annals, 2011 - journals.healio.com
Several new treatments for attention-deficit/hyperactivity disorder have been developed in
recent years. For the most part, new commercial products during this time have been …

¿ Suspender o no el tratamiento?¿ Durante cuánto tiempo debe mantenerse el tratamiento farmacológico del trastorno por déficit de atención/hiperactividad?

GHH van de Loo-Neus, N Rommelse, JK Buitelaar - Psiquiatría Biológica, 2011 - Elsevier
El trastorno por déficit de atención/hiperactividad (TDAH) es un trastorno neuropsiquiátrico
frecuente, con una intensa persistencia a lo largo del tiempo. Con frecuencia se utiliza …

ADHD and Other Disorders of Attention Regulation

H Steiner, PG Stemmle, RE Hall… - Handbook Of …, 2011 - books.google.com
Attention regulation is a core piece of human mental functioning. As only approximately 5%
of all mentation is conscious, 1 human beings have developed a system that reliably and …